- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 15/88 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using liposome vesicle
Patent holdings for IPC class C12N 15/88
Total number of patents in this class: 1468
10-year publication summary
70
|
61
|
73
|
99
|
131
|
150
|
144
|
155
|
231
|
65
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Modernatx, Inc. | 1181 |
69 |
Translate bio, Inc. | 394 |
54 |
Massachusetts Institute of Technology | 9795 |
33 |
The Johns Hopkins University | 5377 |
29 |
The Regents of the University of California | 18943 |
25 |
Arbutus Biopharma Corporation | 183 |
23 |
Flagship Pioneering Innovations V, Inc. | 208 |
22 |
The University of British Columbia | 1432 |
20 |
BioNTech SE | 482 |
19 |
Life Technologies Corporation | 3068 |
17 |
Board of Regents, The University of Texas System | 5370 |
16 |
Alnylam Pharmaceuticals, Inc. | 1066 |
15 |
Protiva Biotherapeutics, Inc. | 41 |
15 |
Intellia Therapeutics, Inc. | 159 |
14 |
Evox Therapeutics Ltd. | 78 |
13 |
National University Corporation Hokkaido University | 1323 |
12 |
Sirna Therapeutics, Inc. | 122 |
12 |
The Trustees of the University of Pennsylvania | 4122 |
11 |
Molecular Transfer, Inc. | 29 |
11 |
Ohio State Innovation Foundation | 1770 |
11 |
Other owners | 1027 |